ATX 3.28% 6.3¢ amplia therapeutics limited

9th October 2023 AACR OVARIAN CANCER CONFERENCE PRESENTATION •...

  1. 2,130 Posts.
    lightbulb Created with Sketch. 668
    9th October 2023


    AACR OVARIAN CANCER CONFERENCE PRESENTATION

    • Data from preclinical studies in ovarian cancer presented at premier international conference in
    Boston, USA.

    • Results indicate that Amplia’s proprietary FAK inhibitor narmafotinib (AMP945) performs better than standard-of-care in models of chemotherapy-resistant high-grade serous ovarian cancer

    • Data from these studies support clinical study of narmafotinib in ovarian cancer – with plans now commencing with leading international cancer specialists


    I’m guessing it is something to do with this conference ...


    .
 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.3¢
Change
0.002(3.28%)
Mkt cap ! $17.11M
Open High Low Value Volume
6.2¢ 6.5¢ 6.1¢ $49.07K 778.9K

Buyers (Bids)

No. Vol. Price($)
1 1994 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.3¢ 7737 1
View Market Depth
Last trade - 12.11pm 03/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.